ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Rating of "Moderate Buy" from Analysts
ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has been given an average rating of “Moderate Buy” by the seven analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price target […]